291 GENES FOUND

? »

« prev | Page of 6 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PLA2G4APhospholipase A2, group IVA (cytosolic, calcium-dependent)Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Mixed
PLATPlasminogen activator, tissueCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Mixed
PLAURPlasminogen activator, urokinase receptorCancer-related genes
CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
PLGPlasminogenCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
PLIN3Perilipin 3FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
PNLIPPancreatic lipaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
PNPPurine nucleoside phosphorylaseCytoskeleton related proteins
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
POLA1Polymerase (DNA directed), alpha 1, catalytic subunitEnzymes
FDA approved drug targets
Predicted intracellular proteins
Expressed in all
POLBPolymerase (DNA directed), betaEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
POLEPolymerase (DNA directed), epsilon, catalytic subunitCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
POLE2Polymerase (DNA directed), epsilon 2, accessory subunitEnzymes
FDA approved drug targets
Predicted intracellular proteins
Mixed
PPARGPeroxisome proliferator-activated receptor gammaCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
Expressed in all
PRDX5Peroxiredoxin 5Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Predicted intracellular proteins
Expressed in all
PRKAA1Protein kinase, AMP-activated, alpha 1 catalytic subunitEnzymes
FDA approved drug targets
Predicted intracellular proteins
Expressed in all
PRKAB1Protein kinase, AMP-activated, beta 1 non-catalytic subunitFDA approved drug targets
Predicted intracellular proteins
Expressed in all
PROCProtein C (inactivator of coagulation factors Va and VIIIa)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
PROS1Protein S (alpha)Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
PSMB1Proteasome (prosome, macropain) subunit, beta type, 1Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
PSMB10Proteasome (prosome, macropain) subunit, beta type, 10Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
PSMB2Proteasome (prosome, macropain) subunit, beta type, 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
PSMB5Proteasome (prosome, macropain) subunit, beta type, 5Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
PSMB8Proteasome (prosome, macropain) subunit, beta type, 8Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
PSMB9Proteasome (prosome, macropain) subunit, beta type, 9Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
PSMD1Proteasome (prosome, macropain) 26S subunit, non-ATPase, 1FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
PSMD2Proteasome (prosome, macropain) 26S subunit, non-ATPase, 2FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
PTGS1Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
PTGS2Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enhanced
QPRTQuinolinate phosphoribosyltransferaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
RARARetinoic acid receptor, alphaCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transcription factors
Expressed in all
RARBRetinoic acid receptor, betaCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Mixed
RARGRetinoic acid receptor, gammaCancer-related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
Tissue enhanced
RETRet proto-oncogeneCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
RPL3Ribosomal protein L3FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Ribosomal proteins
Expressed in all
RRM1Ribonucleotide reductase M1Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
RRM2Ribonucleotide reductase M2Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
RRM2BRibonucleotide reductase M2 B (TP53 inducible)Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
RXRARetinoid X receptor, alphaCancer-related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Expressed in all
RXRBRetinoid X receptor, betaCancer-related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Expressed in all
RYR1Ryanodine receptor 1 (skeletal)Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enriched
SCN2ASodium channel, voltage-gated, type II, alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
SCNN1DSodium channel, non-voltage-gated 1, delta subunitFDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
SERPINB2Serpin peptidase inhibitor, clade B (ovalbumin), member 2Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
SERPINC1Serpin peptidase inhibitor, clade C (antithrombin), member 1Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
SERPIND1Serpin peptidase inhibitor, clade D (heparin cofactor), member 1Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
SHMT1Serine hydroxymethyltransferase 1 (soluble)Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
SISucrase-isomaltase (alpha-glucosidase)Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Group enriched
SIGMAR1Sigma non-opioid intracellular receptor 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
SIRT5Sirtuin 5FDA approved drug targets
Predicted intracellular proteins
Expressed in all
SLC12A1Solute carrier family 12 (sodium/potassium/chloride transporter), member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC12A3Solute carrier family 12 (sodium/chloride transporter), member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enriched

« prev | Page of 6 | next »